These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 1917994)
1. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction. Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994 [TBL] [Abstract][Full Text] [Related]
2. Conversion of 1-O-[3H]alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils. Venable ME; Nieto ML; Schmitt JD; Wykle RL J Biol Chem; 1991 Oct; 266(28):18691-8. PubMed ID: 1917993 [TBL] [Abstract][Full Text] [Related]
3. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation. Venable ME; Olson SC; Nieto ML; Wykle RL J Biol Chem; 1993 Apr; 268(11):7965-75. PubMed ID: 8463317 [TBL] [Abstract][Full Text] [Related]
4. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. Chilton FH; Ellis JM; Olson SC; Wykle RL J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535 [TBL] [Abstract][Full Text] [Related]
5. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. Triggiani M; Connell TR; Chilton FH J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931 [TBL] [Abstract][Full Text] [Related]
6. Selective deacylation of arachidonate-containing ethanolamine-linked phosphoglycerides in stimulated human neutrophils. Tessner TG; Greene DG; Wykle RL J Biol Chem; 1990 Dec; 265(34):21032-8. PubMed ID: 2250009 [TBL] [Abstract][Full Text] [Related]
7. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils. Winkler JD; Sung CM; Hubbard WC; Chilton FH Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523 [TBL] [Abstract][Full Text] [Related]
8. The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity. Blank ML; Smith ZL; Fitzgerald V; Snyder F Biochim Biophys Acta; 1995 Feb; 1254(3):295-301. PubMed ID: 7857969 [TBL] [Abstract][Full Text] [Related]
9. A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway. Uemura Y; Lee TC; Snyder F J Biol Chem; 1991 May; 266(13):8268-72. PubMed ID: 2022643 [TBL] [Abstract][Full Text] [Related]
10. A novel CoA-independent transacetylase produces the ethanolamine plasmalogen and acyl analogs of platelet-activating factor (PAF) with PAF as the acetate donor in HL-60 cells. Lee TC; Uemura Y; Snyder F J Biol Chem; 1992 Oct; 267(28):19992-20001. PubMed ID: 1400315 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes. Ramesha CS; Pickett WC J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991 [TBL] [Abstract][Full Text] [Related]
12. Identification of a lysophospholipase C that may be responsible for the biosynthesis of choline plasmalogens by Madin-Darby canine kidney cells. Strum JC; Daniel LW J Biol Chem; 1993 Dec; 268(34):25500-8. PubMed ID: 8244986 [TBL] [Abstract][Full Text] [Related]
13. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes. Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900 [TBL] [Abstract][Full Text] [Related]
14. Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide. Svetlov SI; Liu H; Chao W; Olson MS Biochim Biophys Acta; 1997 Jun; 1346(2):120-30. PubMed ID: 9219895 [TBL] [Abstract][Full Text] [Related]
15. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes. Sugiura T; Fukuda T; Masuzawa Y; Waku K Biochim Biophys Acta; 1990 Dec; 1047(3):223-32. PubMed ID: 2123719 [TBL] [Abstract][Full Text] [Related]
16. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2. Billah MM; Bryant RW; Siegel MI J Biol Chem; 1985 Jun; 260(11):6899-906. PubMed ID: 3922982 [TBL] [Abstract][Full Text] [Related]
17. Comparison of acceptor and donor substrates in the CoA-independent transacylase reaction in human neutrophils. Nixon AB; Greene DG; Wykle RL Biochim Biophys Acta; 1996 May; 1300(3):187-96. PubMed ID: 8679683 [TBL] [Abstract][Full Text] [Related]
18. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells. Botitsi E; Mavri-Vavayanni M; Siafaka-Kapadai A J Lipid Res; 1998 Jun; 39(6):1295-304. PubMed ID: 9643362 [TBL] [Abstract][Full Text] [Related]
19. CD2 triggering stimulates the formation of platelet-activating factor-acether from alkyl-arachidonoyl-glycerophosphocholine in a human CD4+ T lymphocyte clone. Le Gouvello S; Vivier E; Debre P; Thomas Y; Colard O J Immunol; 1992 Aug; 149(4):1289-93. PubMed ID: 1354232 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells. Chepenik KP; Wykle RL Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]